Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2024 Dec 1;25(12):4211-4216.
doi: 10.31557/APJCP.2024.25.12.4211.

Performance of HPV Self-Sample Collected by a Novel Kit in Comparison with Clinician Collected Sample for Cervical Cancer Screening

Smita Joshi  1 , B Kishore Kumar  2 , Vijayalakshmi Ramshankar  3 , Nandita Maitra  4 , Sayantani Pramanik Palit  5 , Soundharya Ravindran  3 , Twinkle Sara Shyam  4
Affiliations
Comparative Study

Performance of HPV Self-Sample Collected by a Novel Kit in Comparison with Clinician Collected Sample for Cervical Cancer Screening

Smita Joshi et al. Asian Pac J Cancer Prev. .

Abstract

Background and objectives: We are reporting the performance of HPV self-sample collected by a novel kit in comparison with clinician collected cervical sample for HPV testing for cervical cancer screening.

Methods: Consenting, eligible women aged 25 to 60, with a positive cervical cancer screening test report in the past one year but without any prior treatment for cervical abnormalities were enrolled in the study. Each woman provided 2 samples for the HPV test (vaginal self-sample collected with the CERVICHECKTM, an indigenous kit from India and cervical sample collected by the clinician). These samples were analysed using cobas HPV test on 4800 platform and for liquid-based cytology.

Results: We enrolled 156 eligible, consenting participants at 2 study sites. The agreement for the sample collected by CERVICHECKTM and clinician collected sample for any high-risk HPV was 95.1% (k= 0.90, SE 0.036, 95% CI 0.83-0.97). The agreement for HPV 16 or 18 only was 95.1%, (k=0.88, SE 0.045, 95% CI 0.79-0.97). The overall acceptability of the kit was good, participants expressed that self-sampling was easy and > 90% women were willing to recommend it to their friends.

Interpretation and conclusions: There was almost perfect or perfect agreement between the HPV self-sample collected by CERVICHECKTM and clinician collected cervical sample. Self-sampling was highly acceptable to the participating women.

Keywords: Cervical cancer; HPV; cervical cancer screening; self-sample.

PubMed Disclaimer

Conflict of interest statement

Sayantani Pramanik Palit is a co-founder of Pragmatech Healthcare Solutions Pvt. Ltd. She did not have any involvement in the conduct of the study, data acquisition and data analysis. The remaining authors do not have any conflict of interest.

References

    1. Ferlay J, Ervik M, Lam F, Laversanne M, Colombet M, Mery L, Piñeros M, Znaor A, Soerjomataram I, Bray F. Global Cancer Observatory: Cancer Today (version 1 1) Lyon: France: International Agency for Research on Cancer; 2024.
    1. Zhao S, Huang L, Basu P, Domingo EJ, Supakarapongkul W, Ling WY, et al. Cervical cancer burden, status of implementation and challenges of cervical cancer screening in Association of Southeast Asian Nations (ASEAN) countries. Cancer Lett. 2022;525:22–32. - PubMed
    1. WHO. [cited 2023 Apr 25] Cervical Cancer Elimination Initiative. Available from: https://www.who.int/initiatives/cervical-cancer-elimination-initiative.
    1. Brisson M, Kim JJ, Canfell K, Drolet M, Gingras G, Burger EA, et al. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries. Lancet. 2020;395(10224):575. - PMC - PubMed
    1. Arbyn M, Ronco G, Anttila A, Chris CJL, Poljak M, Ogilvie G, et al. Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer. Vaccine. 2012;30(SUPPL.5) - PubMed

Publication types